J&J-backed HistoSonics explores sale at $2.5 billion valuation, FT reports

  • HistoSonics, a medical technology company backed by Johnson & Johnson , is exploring a potential sale after receiving multiple takeover approaches, the Financial Times reported on Friday, citing people familiar with the matter.